about
Progresses towards safe and efficient gene therapy vectorsHuman Leukocyte Antigen Diversity: A Southern African PerspectiveThe role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a reviewMitochondrial transfer: Implications for assisted reproductive technologiesEndothelial cells of the human microvasculature express epidermal fatty acid-binding proteinHypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemiaPharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeCharacterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2Pilot social feasibility study for the establishment of a public human umbilical cord blood stem cell bank in South Africa.Cystic fibrosis on the African continent.Mixed arterio-venous insufficiency in random skin flaps in the rat: is the application of medicinal leeches beneficial?Active-site inactivated FVIIa decreases thrombosis and necrosis in a random skin flap model of acute ischemia.Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.Altered expression of platelet factor 4 and basic fibroblast growth factor correlates with the inhibition of tumor growth in mice.Establishing a public umbilical cord blood stem cell bank for South Africa: an enquiry into public acceptability.Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.Phytoestrogens and inhibition of angiogenesis.Identification of transcription factors potentially involved in human adipogenesis in vitroRole of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.Molecular characterization of lymphatic endothelial cells.Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort studyInhibition of endothelial wound repair by dominant negative connexin inhibitors.Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.Hereditary vascular anomalies: new insights into their pathogenesis.Literature watch. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.Visualizing function in the tumor-associated lymphatic system.Genistein, a dietary-derived inhibitor of in vitro angiogenesisUrokinase-type plasminogen activator is induced in migrating capillary endothelial cellsJunctional communication is induced in migrating capillary endothelial cells.Lymphangiogenesis in human gynaecological cancers.Wharton's Jelly-Derived Mesenchymal Stromal Cells and Fibroblast-Derived Extracellular Matrix Synergistically Activate Apoptosis in a p21-Dependent Mechanism in WHCO1 and MDA MB 231 Cancer Cells In Vitro.Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort.Obesity in South Africa.Novel flow cytometric approach for the detection of adipocyte subpopulations during adipogenesis.Opportunities and barriers to establishing a cell therapy programme in South Africa.Fibroblast-Derived Extracellular Matrix Induces Chondrogenic Differentiation in Human Adipose-Derived Mesenchymal Stromal/Stem Cells in Vitro.Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro.Circulating and imaging markers for angiogenesis.Curbing stem cell tourism in South Africa.
P50
Q26781432-77D73D55-6E92-4E84-A2AF-AB2EA4F97651Q26782686-594E264D-128D-465C-AEE4-62377FE57C7BQ26996186-4087A68F-3945-46EE-BD87-303DE0452240Q28066343-3A7F02F3-CE43-4F63-B435-E2B3960F93CBQ28248083-BC1EB993-DFD1-4B03-AA5F-EE758B5AC14CQ28344343-A874EC2E-C679-418F-B655-4741E02765B6Q28392069-4158301E-00D7-456E-8B54-20AE2AF5440AQ28580820-31F33FB9-7155-4D49-A5AF-4B8D330A0B57Q30224561-F92FE0C9-6116-4768-A700-76BDA6B1AE63Q30252014-350B5934-AB39-4597-952A-DA12E69B8E90Q30844703-D2A2D6E2-6F06-4370-A683-F90B380E97F9Q31130810-72CDFF0A-3F92-4BE0-B260-24E19785D77BQ33203025-23396896-929F-4392-9AA6-2CFE81FF2A34Q33420225-F99A7CAC-A7B7-41DF-914D-D16520FC3183Q33455911-AAA65820-3932-4DB1-AE44-ED0E39D457EAQ33597563-5D67CC51-C290-4093-94EF-84FE668B1958Q33671881-4D4B9C0A-61E5-4080-9787-F883611DF6B7Q33718556-9B0641D3-3175-47F0-9104-71ADDBF857AFQ34307809-1EAAEAC2-2F58-47FA-806A-0E30DB1D833DQ34415420-FD45B0E3-CDB9-486B-BCAB-C2F1CAF1C285Q34565428-34849968-5FE3-4DB2-B64D-6FAE54CB3184Q35581431-C2224425-FF98-4397-B0A4-CEA7059604BEQ35584999-501A50F8-534B-4B90-9DFF-9AA58F9D60C8Q35745432-00591B72-4C9D-4E80-8C10-61CD82082B58Q35825239-A9E81666-392C-41AA-BF4C-0B5C6FCB5784Q35996087-86006398-D518-41B1-8128-2066FE1EB12AQ36009331-C797CD53-E3FC-4BDB-922F-C23D96690482Q36192742-19CA0C03-C445-4C93-91A0-14329A9A24ADQ36217171-B49024C5-A663-41AB-8344-6D22C5192CB5Q36222077-6961976E-07A9-43D5-8F83-491DF56C88D2Q36279887-2992CA6D-218E-4012-A8DC-F043A74402B3Q36532173-8B77D7B4-3128-450D-A12A-DEE5E14F8104Q36556433-7E1CB0D0-971F-433E-955B-589DB7A129F3Q36622223-ECE4C381-784A-452F-BD42-217706B0A89DQ36731731-9EF7992B-3ADB-4FC9-9A6A-C772F23DAD1BQ36998666-2DB3CEB0-BAF8-4343-B2F3-E326065EB7B1Q37209984-04F4F0F2-25C6-4511-BD9E-ADB305273267Q37256383-48769B52-D7D0-44F6-ACEE-07429E6FEED7Q37299872-691DF0E7-49C0-4C9B-BFC4-FE33358246E5Q37463864-7CCD06BD-683E-46D4-9FB7-B8F79F2CBE55
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6406-2380
@en
name
Michael S Pepper
@ast
Michael S Pepper
@en
Michael S Pepper
@es
Michael S Pepper
@nl
type
label
Michael S Pepper
@ast
Michael S Pepper
@en
Michael S Pepper
@es
Michael S Pepper
@nl
prefLabel
Michael S Pepper
@ast
Michael S Pepper
@en
Michael S Pepper
@es
Michael S Pepper
@nl
P106
P214
4821155044873072520002
P31
P496
0000-0001-6406-2380
P734
P735
P7859
viaf-4821155044873072520002